Corvus Pharmaceuticals, Inc. · NASDAQ:CRVS

Sirenia Capital Management LP reported a 7.50% stake in Corvus Pharmaceuticals, Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed May 15, 2026

Sirenia Capital Management LP reported a 7.50% stake in Corvus Pharmaceuticals, Inc., 6,831,828 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).

Stake
7.50%
Shares
6,831,828
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Sirenia Capital Management LP7.50%6,831,828
Alex Silverstein7.50%6,831,828

Source

View original at SEC

Related